You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ADRUCIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Adrucil, and what generic alternatives are available?

Adrucil is a drug marketed by Pharmacia And Upjohn and Teva Parenteral and is included in four NDAs.

The generic ingredient in ADRUCIL is fluorouracil. There are fifteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Adrucil

A generic version of ADRUCIL was approved as fluorouracil by FRESENIUS KABI USA on September 30th, 1998.

  Try a Trial

Drug patent expirations by year for ADRUCIL
Recent Clinical Trials for ADRUCIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kimberly PerezPhase 2
Colin D. Weekes, M.D.Phase 1
AstraZenecaPhase 2

See all ADRUCIL clinical trials

US Patents and Regulatory Information for ADRUCIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn ADRUCIL fluorouracil INJECTABLE;INJECTION 081222-001 Jun 28, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Parenteral ADRUCIL fluorouracil INJECTABLE;INJECTION 081225-001 Aug 28, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmacia And Upjohn ADRUCIL fluorouracil INJECTABLE;INJECTION 017959-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.